Beta-secretase (BACE) as a drug target for Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Advanced Drug Delivery Reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12453676
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production.

  2001cited by this paper
• Characterization of the Glycosylation Profiles of Alzheimer's β-Secretase Protein Asp-2 Expressed in a Variety of Cell Lines*

  2001cited by this paper
• Mechanism of Inhibition of β-Site Amyloid Precursor Protein-cleaving Enzyme (BACE) by a Statine-based Peptide*

  2001cited by this paper
• Association studies using novel polymorphisms in BACE1 and BACE2

  2001cited by this paper
• The BACE gene: genomic structure and candidate gene study in late-onset Alzheimer's disease

  2001cited by this paper
• The Pro Domain of β-Secretase Does Not Confer Strict Zymogen-like Properties but Does Assist Proper Folding of the Protease Domain*

  2001cited by this paper
• A Splice Variant of β-Secretase Deficient in the Amyloidogenic Processing of the Amyloid Precursor Protein*

  2001cited by this paper
• Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.

  2001cited by this paper
• Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10.

  2001cited by this paper
• Processing of β-Secretase by Furin and Other Members of the Proprotein Convertase Family*

  2001cited by this paper
• BACE2 Functions as an Alternative α-Secretase in Cells*

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics.

  2001cited by this paper
• BACE1 is the major beta-secretase for generation of Abeta peptides by neurons.

  2001cited by this paper
• Prodomain Processing of Asp1 (BACE2) Is Autocatalytic*

  2001cited by this paper
• Phosphorylation regulates intracellular trafficking of beta-secretase.

  2001cited by this paper
• Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties.

  2000cited by this paper
• Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain.

  2000cited by this paper
• Expression Analysis of BACE2 in Brain and Peripheral Tissues*

  2000cited by this paper
• Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor.

  2000cited by this paper
• Maturation and pro-peptide cleavage of beta-secretase.

  2000cited by this paper
• A Furin-like Convertase Mediates Propeptide Cleavage of BACE, the Alzheimer's β-Secretase*

  2000cited by this paper
• Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase.

  2000cited by this paper
• Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein.

  2000cited by this paper
• Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein beta-secretase.

  2000cited by this paper
• The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the Down critical region

  2000cited by this paper
• BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein.

  2000cited by this paper
• A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer’s amyloid precursor protein β-secretase

  2000cited by this paper
• Abeta-generating enzymes: recent advances in beta- and gamma-secretase research.

  2000cited by this paper
• Design of Potent Inhibitors for Human Brain Memapsin 2 (β-Secretase).

  2000cited by this paper
• ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site.

  2000cited by this paper
• Function and dysfunction of the presenilins.

  1999cited by this paper
• Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.

  1999cited by this paper
• Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity

  1999cited by this paper
• Purification and cloning of amyloid precursor protein β-secretase from human brain

  1999cited by this paper
• Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

  1999cited by this paper
• Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease.

  1999cited by this paper
• Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity

  1999cited by this paper
• Identification of a novel aspartic protease (Asp 2) as beta-secretase.

  1999cited by this paper
• Generation and regulation of beta-amyloid peptide variants by neurons.

  1998cited by this paper
• Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor.

  1998cited by this paper
• The role of A beta 42 in Alzheimer's disease.

  1998cited by this paper
• Genetics of Alzheimer's disease.

  1998cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• β-Secretase Processing of the β-Amyloid Precursor Protein in Transgenic Mice Is Efficient in Neurons but Inefficient in Astrocytes*

  1996cited by this paper
• The Vacuolar H-ATPase Inhibitor Bafilomycin A1 Differentially Affects Proteolytic Processing of Mutant and Wild-type -Amyloid Precursor Protein (*)

  1995cited by this paper
• Generation of amyloid beta protein from its precursor is sequence specific.

  1995cited by this paper
• Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro.

  1995cited by this paper
• The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway

  1995cited by this paper
• Cell-type and Amyloid Precursor Protein-type Specific Inhibition of Aβ Release by Bafilomycin A1, a Selective Inhibitor of Vacuolar ATPases (*)

  1995cited by this paper
• Evidence that production and release of amyloid beta-protein involves the endocytic pathway.

  1994cited by this paper
• beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms.

  1993cited by this paper
• Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide.

  1993cited by this paper
• Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.

  1993cited by this paper
• A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

  1992cited by this paper
• Amyloid beta-peptide is produced by cultured cells during normal metabolism.

  1992cited by this paper
• A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

  1991cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper
• Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

  1987cited by this paper

• Long non‐coding RNAs as key regulators of neurodegenerative protein aggregation

  2025cites this paper
• Rational design of novel diaryl ether-linked benzimidazole derivatives as potent and selective BACE1 inhibitors.

  2024cites this paper
• Navigating the Maze of Alzheimer's Disease by Exploring BACE1: Discovery, Current Scenario, and Future Prospects.

  2024cites this paper
• Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs

  2024cites this paper
• What Threshold of Amyloid Reduction Is Necessary to Meaningfully Improve Cognitive Function in Transgenic Alzheimer’s Disease Mice?

  2024cites this paper
• Identifying β-secretase 1 (BACE1) inhibitors from plant-based compounds: an approach targeting Alzheimer’s therapeutics employing molecular docking and dynamics simulation

  2023cites this paper
• Alzheimer’s Disease-Related Epigenetic Changes: Novel Therapeutic Targets

  2023cites this paper
• An insight into the neuroprotective effects and molecular targets of pomegranate (Punica granatum ) against Alzheimer’s disease

  2022cites this paper
• In silico screening of potential β-secretase (BACE1) inhibitors from VIETHERB database

  2022cites this paper
• Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer’s Disease Neuropathology

  2022cites this paper
• The Swedish dilemma - the almost exclusive use of APPswe-based mouse models impedes adequate evaluation of alternative β-secretases.

  2021cites this paper
• PET Agents in Dementia: An Overview.

  2021cites this paper
• Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer's Disease.

  2021cites this paper
• BACE1 and cholinesterase inhibitory activities of compounds from Cajanus cajan and Citrus reticulata: an in silico study

  2021cites this paper
• Strategic approaches to target the enzymes using natural compounds for the management of Alzheimer's disease: A review.

  2021cites this paper
• Astrocytes & Astrocyte derived Extracellular Vesicles in Morphine Induced Amyloidopathy: Implications for Cognitive Deficits in Opiate Abusers

  2021influential citation
• A novel phytochemical from Dipteris wallichii inhibits human β-secretase 1: Implications for the treatment of Alzheimer's disease.

  2020cites this paper
• Nanomedicine against Alzheimer's and Parkinson's disease.

  2020cites this paper
• A Close Look at BACE1 Inhibitors for Alzheimer’s Disease Treatment

  2019cites this paper
• In vivo Evaluation and Alzheimer's Disease Treatment Outcome of siRNA Loaded Dual Targeting Drug Delivery System.

  2019cites this paper
• Acylguanidine-BACE1 complex: Insights of intermolecular interactions and dynamics.

  2019cites this paper
• Non‐viral nucleic acid delivery to the central nervous system and brain tumors

  2019cites this paper
• Regulation of the alternative β-secretase meprin β by ADAM-mediated shedding

  2019cites this paper
• Use of Peptides for the Management of Alzheimer’s Disease: Diagnosis and Inhibition

  2018cites this paper
• Expression analysis of beta-secretase 1 (BACE1) and its naturally occurring antisense (BACE1-AS) in blood of epileptic patients

  2018cites this paper
• Compound CID 9998128 Is a Potential Multitarget Drug for Alzheimer's Disease.

  2018cites this paper
• Comparative molecular docking studies of lupeol and lupenone isolated from Pueraria lobata that inhibits BACE1: Probable remedies for Alzheimer's disease.

  2017cites this paper
• Multi-target-directed therapeutic potential of 7-methoxytacrine-adamantylamine heterodimers in the Alzheimer's disease treatment.

  2017cites this paper
• Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.

  2017cites this paper
• Neuroprotective effects of honokiol: from chemistry to medicine

  2017cites this paper
• Role of BACE1 in Alzheimer’s synaptic function

  2017cites this paper
• Application of Chitosan, Chitooligosaccharide, and Their Derivatives in the Treatment of Alzheimer’s Disease

  2017cites this paper
• Discovery and characterization of novel indole and 7-azaindole derivatives as inhibitors of β-amyloid-42 aggregation for the treatment of Alzheimer's disease.

  2017cites this paper
• Biomedical Applications of Acridines

  2017cites this paper
• Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.

  2017cites this paper
• Multi-structure docking analysis of BACE1 crystal structures and non-peptidic ligands.

  2017cites this paper
• Inhibition of β-Secretase Activity by Monoterpenes, Sesquiterpenes, and C13 Norisoprenoids.

  2017cites this paper
• The Metalloprotease Meprin β Is an Alternative β-Secretase of APP

  2017cites this paper
• Kinetics and molecular docking studies of loganin, morroniside and 7-O-galloyl-d-sedoheptulose derived from Corni fructus as cholinesterase and β-secretase 1 inhibitors

  2016cites this paper
• Sulodexide and Alzheimer’s Disease: A Preliminary Prospective Study

  2016cites this paper
• Osthole decreases beta amyloid levels through up-regulation of miR-107 in Alzheimer's disease.

  2016cites this paper
• 2,2,2-Trifluoroethyl-thiadiazines: a patent evaluation of WO2016023927

  2016cites this paper
• Investigation of flap flexibility of β-secretase using molecular dynamic simulations

  2016cites this paper
• Surface plasmon resonance biosensors for simultaneous monitoring of amyloid-beta oligomers and fibrils and screening of select modulators.

  2016cites this paper
• Kinetics and molecular docking studies of loganin, morroniside and 7-O-galloyl-d-sedoheptulose derived from Corni fructus as cholinesterase and β-secretase 1 inhibitors

  2016cites this paper
• Physiologically generated presenilin 1 lacking exon 8 fails to rescue brain PS1−/− phenotype and forms complexes with wildtype PS1 and nicastrin

  2015cites this paper
• Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.

  2015cites this paper
• Enhanced BBB permeability of osmotically active poly(mannitol-co-PEI) modified with rabies virus glycoprotein via selective stimulation of caveolar endocytosis for RNAi therapeutics in Alzheimer's disease.

  2015cites this paper
• Luteinizing hormone as a key player in the cognitive decline of Alzheimer's disease.

  2015cites this paper
• Study on the active mechanism of β-secretase inhibitors by molecular simulations.

  2015cites this paper
• Protective effects of bajijiasu in a rat model of Aβ₂₅₋₃₅-induced neurotoxicity.

  2014cites this paper
• Alzheimer's disease, enzyme targets and drug discovery struggles: from natural products to drug prototypes.

  2014cites this paper
• Nanotechnology and Alzheimer's disease: what has been done and what to do.

  2014cites this paper
• Cholinesterase inhibitors from the roots of Harpagophytum procumbens

  2014cites this paper
• A new insight into computational molecular design: A case study on BACE-1 inhibitors

  2014cites this paper
• METAPLASTICITY IN A MOUSE MODEL OF ALZHEIMER’S DISEASE AND POSSIBLE THERAPEUTIC INTERVENTIONS

  2014cites this paper
• 2D QSAR studies on series of human beta-secretase (BACE-1) inhibitors.

  2014cites this paper
• Postsynaptic Target Specific Synaptic Dysfunctions in the CA3 Area of BACE1 Knockout Mice

  2014cites this paper
• Potent Acetylcholinesterase Inhibitory Compounds from Myristica fragrans

  2014cites this paper
• BACE1 and cholinesterase inhibitory activities of Nelumbo nucifera embryos

  2014cites this paper
• Structure-based β-secretase (BACE1) inhibitors.

  2014cites this paper
• Anti-Cholinesterase Activity of Lycopodium Alkaloids from Vietnamese Huperzia squarrosa (Forst.) Trevis

  2014cites this paper
• Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes

  2013cites this paper
• Amyloid Peptide Self-Assembly in Protic Ionic Liquids

  2013cites this paper
• Characterization and in vitro permeation study of microemulsions and liquid crystalline systems containing the anticholinesterase alkaloidal extract from Tabernaemontana divaricata.

  2013cites this paper
• Design and synthesis of novel 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridines as small molecule BACE-1 inhibitors.

  2013cites this paper
• Indole and trans-chalcone attenuate amyloid β plaque accumulation in male Wistar rat: in vivo effectiveness of two anti-amyloid scaffolds.

  2013cites this paper
• Effects of berberine on β-secretase activity in a rabbit model of Alzheimer's disease

  2013cites this paper
• Cholinesterase inhibitors from the roots of Harpagophytum procumbens

  2013cites this paper
• Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes

  2013influential citation
• AβPP-Selective BACE Inhibitors (ASBI): Novel Class of Therapeutic Agents for Alzheimer's Disease

  2013cites this paper
• Efficient Screening of Marine Extracts for Protease Inhibitors by Combining FRET Based Activity Assays and Surface Plasmon Resonance Spectroscopy Based Binding Assays

  2013cites this paper
• Aspartic Peptidases of Human Pathogenic Trypanosomatids: Perspectives and Trends for Chemotherapy

  2013cites this paper
• High throughput virtual screening and E-pharmacophore filtering in the discovery of new BACE-1 inhibitors

  2013cites this paper
• Ab initio modeling of a potent isophthalamide-based BACE-1 inhibitor: amino acid decomposition analysis

  2013cites this paper
• Identification of BACE1 inhibitors from Panax ginseng saponins - An Insilco approach

  2013cites this paper
• Identification of BACE2 as an avid ß-amyloid-degrading protease

  2012cites this paper
• Promotion of β-amyloid production by C-reactive protein and its implications in the early pathogenesis of Alzheimer's disease.

  2012cites this paper
• Exploring the binding of BACE-1 inhibitors using comparative binding energy analysis (COMBINE)

  2012cites this paper
• Roles of AMP-activated Protein Kinase in Alzheimer’s Disease

  2012cites this paper
• Lipids in Alzheimer’s disease and their potential for therapy

  2012cites this paper
• BACE1 in Alzheimer's disease.

  2012cites this paper
• Consequences of Inhibiting Amyloid Precursor Protein Processing Enzymes on Synaptic Function and Plasticity

  2012cites this paper
• Imidazoline derivatives: a patent review (2006 – present)

  2012cites this paper
• Membrane Trafficking Pathways in Alzheimer's Disease

  2012cites this paper
• Characterisation of different amyloid-ß aggregates in Alzheimer's disease

  2012cites this paper
• The BACE1-PSEN-AβPP Regulatory Axis has an Ancient Role in Response to Low Oxygen/Oxidative Stress

  2012cites this paper
• Circuit Analysis of Synaptic Dysfunctions in the CA3 Area of BACE1 Knockout Mice

  2012influential citation
• Fluorogenic quantum dot-gold nanoparticle assembly for beta secretase inhibitor screening in live cell.

  2012cites this paper
• Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells

  2012cites this paper
• Alzheimer's Therapeutics: Translation of Preclinical Science to Clinical Drug Development

  2012cites this paper
• Opioid System and Alzheimer’s Disease

  2012cites this paper
• Inhibitory Evaluation of Sulfonamide Chalcones on β-Secretase and Acylcholinesterase

  2012cites this paper
• Involvement of Receptor Tyrosine Kinase Tyro3 in Amyloidogenic APP Processing and β-Amyloid Deposition in Alzheimer's Disease Models

  2012cites this paper
• Quantum mechanics study of the hydroxyethylamines–BACE-1 active site interaction energies

  2011cites this paper
• Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues.

  2011cites this paper
• Membrane Anchored and Lipid Raft Targeted β-Secretase Inhibitors for Alzheimer's Disease Therapy

  2011cites this paper
• Human pyroglutamyl peptidases and their involvement in Alzheimer's disease

  2011cites this paper
• Oxidative Stress and β-Amyloid Protein in Alzheimer’s Disease

  2011cites this paper
• Aspartic protease inhibitors as potential anti-Candida albicans drugs: impacts on fungal biology, virulence and pathogenesis.

  2011cites this paper